the three-year event rate for nonfatal stroke or death from any cause was 17 percent for ticlopidine and 19 percent for aspirin -- a 12 percent risk reduction ( 95 percent confidence interval , -2 to 26 percent ) with ticlopidine ( p = 0.048 for cumulative kaplan-meier estimates ) .
C0038454
stroke
C0040207
ticlopidine